Brief: Nykode Therapeutics Q3 Oper Loss Widens To $19.9 Million
Nov 23 (Reuters) - Nykode Therapeutics ASA NYKD.OL :
* Q3 OPERATING LOSS USD 19.9 MILLION VERSUS LOSS USD 10.3
MILLION
YEAR AGO
* Q3 TOTAL REVENUE AND OTHER INCOME $1.3 MILLION VERSUS $1.3
MILLION YEAR AGO
Source text for Eikon: ID:nObiJmGwDa
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026